The global average life expectancy is projected to rise to 80 years by 2040[1].Since cancer is closely linked to aging,its prevalence is expected to grow as the population ages.Advancements in cancer diagnosis and tre...The global average life expectancy is projected to rise to 80 years by 2040[1].Since cancer is closely linked to aging,its prevalence is expected to grow as the population ages.Advancements in cancer diagnosis and treatment have led to an increasing number of cancer survivors.In a 2021 consensus statement,the International Society for Geriatric Oncology updated its top priorities for improving care for older cancer patients[2,3].According to the Global Burden of Disease(GBD)study,there were over four million deaths from gastrointestinal(GI)cancer in 2021[4].The aging population,advancements in cancer management,and shifting risk factors are undoubtedly influencing the prevalence of GI cancers in older adults[5].While aging has increasingly captured the attention of policymakers and stakeholders,epidemiological data on GI cancers in older adults remains limited.Older patients are also underrepresented in GI-specific clinical trials.This study aimed to estimate the global burden of GI cancers in older adults using the most recent GBD 2021[6].展开更多
文摘The global average life expectancy is projected to rise to 80 years by 2040[1].Since cancer is closely linked to aging,its prevalence is expected to grow as the population ages.Advancements in cancer diagnosis and treatment have led to an increasing number of cancer survivors.In a 2021 consensus statement,the International Society for Geriatric Oncology updated its top priorities for improving care for older cancer patients[2,3].According to the Global Burden of Disease(GBD)study,there were over four million deaths from gastrointestinal(GI)cancer in 2021[4].The aging population,advancements in cancer management,and shifting risk factors are undoubtedly influencing the prevalence of GI cancers in older adults[5].While aging has increasingly captured the attention of policymakers and stakeholders,epidemiological data on GI cancers in older adults remains limited.Older patients are also underrepresented in GI-specific clinical trials.This study aimed to estimate the global burden of GI cancers in older adults using the most recent GBD 2021[6].
